⟵ Back to Search Results

BGB-3111_GA101_Study_001

Completed

BGB 3111 in Combination With Obinutuzumab in Participants With B-Cell Lymphoid Malignancies

Beigene Study ID info

BGB-3111_GA101_Study_001

ClinicalTrials.gov ID info

NCT02569476

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All

Age: 18 Years / N/A

Study Documents

Study Protocol Statistical Analysis Plan